Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Immune features are associated with response to neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer ; volume:15 ; number:1 ; day:24 ; month:5 ; year:2024 ; pages:1-14 ; date:12.2024
Nature Communications ; 15, Heft 1 (24.5.2024), 1-14, 12.2024
- Creator
-
Beckabir, Wolfgang
Zhou, Mi
Lee, Jin Seok
Vensko, Steven P.
Woodcock, Mark G.
Wang, Hsing-Hui
Wobker, Sara E.
Atassi, Gatphan
Wilkinson, Alec D.
Fowler, Kenneth
Flick, Leah M.
Damrauer, Jeffrey S.
Harrison, Michael R.
McKinnon, Karen P.
Rose, Tracy L.
Milowsky, Matthew I.
Serody, Jonathan S.
Kim, William Y.
Vincent, Benjamin G.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-48480-1
- URN
-
urn:nbn:de:101:1-2408051052344.200114908653
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beckabir, Wolfgang
- Zhou, Mi
- Lee, Jin Seok
- Vensko, Steven P.
- Woodcock, Mark G.
- Wang, Hsing-Hui
- Wobker, Sara E.
- Atassi, Gatphan
- Wilkinson, Alec D.
- Fowler, Kenneth
- Flick, Leah M.
- Damrauer, Jeffrey S.
- Harrison, Michael R.
- McKinnon, Karen P.
- Rose, Tracy L.
- Milowsky, Matthew I.
- Serody, Jonathan S.
- Kim, William Y.
- Vincent, Benjamin G.
- SpringerLink (Online service)
Other Objects (12)
Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
Proteomics research on muscle-invasive bladder transitional cell carcinoma
The natural history of secondary muscle-invasive bladder cancer
Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy
Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer
Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival
Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
Proteomics research on muscle-invasive bladder transitional cell carcinoma